Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the market.
Fundamental & clinical pharmacology June 2022 Jules Baudot, Thomas Soeiro, Marine Tambon et al.
Prominent features of esketamine (e.g., similar mechanism of action as ketamine and target population) require to be vigilant regarding its benefits/risks balance and its risks of abuse in real-life settings. The aim of this study was to review all available pharmacological and clinical data to assess the abuse potential of esketamine shortly after its marketing. This multidimensional study is...